Eyebright Medical Technology (Beijing) Co., Ltd. (SHA: 688050)

Eyebright Medical Technology (Beijing) Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	271.08	536.66	354.9	472.87	536.84	196.33
Short-Term Investments	-	-	-	480	450	-
Trading Asset Securities	198.17	20.12	481.97	0.48	0.28	-
Cash & Short-Term Investments	469.25	556.78	836.86	953.35	987.12	196.33
Cash Growth	-22.68%	-33.47%	-12.22%	-3.42%	402.79%	-27.43%
Accounts Receivable	386.23	212.82	103.52	67.8	74.22	58.3
Other Receivables	4.48	6.03	3.71	6.57	4.69	1
Receivables	390.71	218.85	107.23	74.37	78.91	59.3
Inventory	247.96	181.35	78.83	56.02	59.07	60.78
Prepaid Expenses	-	-	-	0.15	1	0.61
Other Current Assets	70.87	65.89	38.36	34.83	20.08	17.5
Total Current Assets	1,179	1,023	1,061	1,119	1,146	334.52
Property, Plant & Equipment	1,421	1,257	674.21	558.69	267.13	183.13
Long-Term Investments	197.9	157.44	153.56	102.16	40.78	15.94
Goodwill	132.75	132.6	21.13	21.13	-	-
Other Intangible Assets	189.57	174.21	107.04	91.39	90.92	88.58
Long-Term Deferred Tax Assets	47.85	46.74	29.91	34.35	25.12	25.3
Long-Term Deferred Charges	131.45	105.72	60.83	67.49	49.57	19.23
Other Long-Term Assets	106.4	149.43	120.81	45.49	18.83	19.1
Total Assets	3,406	3,062	2,244	2,048	1,639	685.78
Accounts Payable	64.07	49.05	13.86	5.57	2.18	0.28
Accrued Expenses	43.73	50.87	42.59	31.82	17.97	12.75
Short-Term Debt	-	25.55	-	-	-	-
Current Portion of Long-Term Debt	37.82	92.39	-	-	-	-
Current Income Taxes Payable	20.39	2.31	13.5	6.99	4.1	2.3
Current Unearned Revenue	5.46	12.6	6.47	6.16	3.41	-
Other Current Liabilities	76.06	145	71.29	88.88	49.43	7.79
Total Current Liabilities	247.54	377.77	147.71	139.42	77.09	23.13
Long-Term Debt	577.01	287.44	149.77	143.37	-	-
Long-Term Leases	12.86	13.85	13.02	11.48	-	-
Long-Term Unearned Revenue	9.1	10.53	8.9	10.76	12.62	14.62
Long-Term Deferred Tax Liabilities	14.45	15.14	4.26	0.8	-	-
Other Long-Term Liabilities	2.17	1.13	0.64	1.63	1.18	0.51
Total Liabilities	863.14	705.85	324.3	307.46	90.89	38.26
Common Stock	189.54	105.25	105.18	105.14	105.14	78.85
Additional Paid-In Capital	1,193	1,325	1,311	1,318	1,305	527.53
Retained Earnings	965.9	699.81	444.01	250.23	107.74	11.18
Total Common Equity	2,330	2,130	1,860	1,674	1,518	617.56
Minority Interest	212.59	226.3	59.96	66.29	29.53	29.97
Shareholders' Equity	2,543	2,356	1,920	1,740	1,548	647.52
Total Liabilities & Equity	3,406	3,062	2,244	2,048	1,639	685.78
Total Debt	627.69	419.23	162.79	154.85	-	-
Net Cash (Debt)	-158.44	137.55	674.07	798.5	987.12	196.33
Net Cash Growth	-	-79.59%	-15.58%	-19.11%	402.79%	-25.04%
Net Cash Per Share	-0.84	0.72	3.56	4.22	6.13	1.39
Filing Date Shares Outstanding	189.54	189.45	189.32	189.25	189.25	141.93
Total Common Shares Outstanding	189.54	189.45	189.32	189.25	189.25	141.93
Working Capital	931.25	645.1	913.59	979.3	1,069	311.39
Book Value Per Share	12.29	11.24	9.83	8.84	8.02	4.35
Tangible Book Value	2,008	1,823	1,732	1,561	1,427	528.98
Tangible Book Value Per Share	10.59	9.62	9.15	8.25	7.54	3.73
Buildings	-	676.61	414.46	150.37	136.27	129.27
Machinery	-	618.13	232.76	155.95	102.28	85.88
Construction In Progress	-	154.26	120.6	318.44	81	3.62

Source: S&P Capital IQ. Standard template. Financial Sources.